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ABSTRACT 
 
The pre-analytical phase contributes 60-70% of total error of the total testing 
process (TTP) (Plebani 2006). The pre-analytical phase can be further divided 
into two phases; the ‘pre-preanalytical’ and ‘preanalytical’ phases, which 
commonly includes tasks performed outside of the laboratory walls, and tasks 
perform within the laboratory’s walls and control, respectively. Additionally, 
medical care reimbursement policies in the U.S. along with the need to efficiently 
produce quality results and reduce the costs to clients, has caused the 
microbiology lab to move from on-site to more resourcefully abundant 
consolidate labs (Sautter 2014).  Serving many satellite facilities, it is of interest 
to look at the pre-preanalytical phase to ensure specimen accountability when 
transported over the distance to the core laboratory.  
 
While automation has assisted in reducing errors in all phases of testing, 
automation in the pre-analytical microbiology laboratory has been slower due to 
its inherent variation (Mulatero 2011). In addition, the lack of well-defined quality 
indicators in the pre-preanalytical phase makes it more difficult to monitor 
possible errors. Plebani encourages the best way to reduce errors in the pre-
preanalytical phase is to work interdepartmentally and monitor compliance to 
standard operating procedures (SOP).  
 
viii 
 
This study utilizes Plebani’s approach to encourage specimen accountability 
between sending facilities and the core microbiology laboratory. Focusing on the 
transportation element in the pre-preanalytical phase, common non-compliance 
issues were identified and used as pre-defined quality indicators to communicate 
as standardized emails to non-compliant departments over of a course of five 
months in 2017. By reaching a consensus on adjustment of workflow and duties, 
quality monitoring data of non-compliance issues had been compiled and 
communicated to enhance specimen accountability at a consolidated core 
microbiology lab without the need of automation in the pre-preanalytical phase.  
 
 
  
 
 
INTRODUCTION 
 
The paradigm of the laboratory testing process has been described as ‘brain-to-
brain loop’ that encompasses the total testing phase (TTP) by Lundberg decades 
ago in 1981. The nine steps of TTP are ordering, collection, identification, 
transportation, preparation, analysis, reporting, interpretation, and action; 
essentially beginning and ending in the mind of physician in order to treat a 
patient (Lungberg 1981). These steps have been classified into three phases: 
pre-analytical, analytical, and post-analytical phases. Quality improvement has 
primarily been focused at the analytical phase, since the wrong result can 
adversely affect patient outcome. With the contribution of standardized 
techniques, reagents, automated instrumentation, information technology, and 
methods in quality control and assurance; error rates in the analytical phase have 
seen a ten-fold reduction (Plebani 2012). 
 
The main contributor of error rates in the TTP stem from the pre-analytical phase 
with a low prevalence of them actually leading to adverse patient outcomes 
(Hawkins 2012). Such errors can delay result turnaround time and patient 
treatment for routine diagnostics. Decrease in customer satisfaction due to the 
need of recollection may affect the perception of quality for the laboratory.  
 
The pre-analytical phase can be further divided into two categories; ‘pre-
preanalytical’ and ‘preanalytical’ (Plebani 2006). ‘Pre-analytical’ activities inside 
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the laboratory  such as sorting and routing, pour-off aliquoting, pipetting and 
mislabeling, and improper centrifugation of specimens account for 3%-5% of the 
total pre-analytical errors (Hawkins 2012). The ‘pre-preanalytical’ tasks 
performed by personnel outside of the laboratory contribute the most error in 
laboratory’s TTP quality. Contributing 46%-68% of errors, the ‘pre-preanalytical’ 
category includes “inappropriate test request, order entry, patient/specimen 
misidentification, sample collection from infusion route, sample collection 
(hemolysis, clotting, insufficient volume, etc.) inappropriate container, handling, 
storage, and transportation” (Hawkins 2012). Well defined quality indicators (QI) 
in the analytical phase monitor laboratory test performance and efficiency, 
however definitions for QI in the pre-analytical phase are not fully established. 
(Plebani 2012). A definition issued by the International Organization for 
Standardization in 2008 states that errors need to be evaluated in all phases of 
TTP, in or out of the laboratory, and centered about patient care. Table 1 lists 
sixteen quality indicators developed by the IFCC Working Group for the pre-
analytical phase based on globally collected data (Sciacovelli 2009). These 
indices do not assess possible patient effects and translate into improvement in 
the laboratory; the best approach for pre-analytical error reduction is to monitor 
adherence to procedures (SOP) and compliance that may vary from institution to 
institution (Plebani 2012).  
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Table 1. Quality indicators in the pre-analytic phase developed by IFCC Working 
Group  
QI-1: Appropriateness of test 
request 
Number of requests with clinical question (%) 
QI-2: Appropriateness of test 
request 
Number of appropriate tests with respect to the clinical 
question (%) 
QI-3: Examination requisition Number of requests without physician’s identification 
(%) 
QI-4: examination requisition Number of unintelligible requests (%) 
QI-5: Identification Number of requests with erroneous patient 
identification (%) 
QI-6: Identification Number of requests with erroneous identification of 
physician (%) 
QI-7: Test request Number of requests with errors concerning test input 
(%) 
QI-8: Samples Number of samples lost/not received (%) 
QI-9: Samples Number of samples collected in inappropriate 
containers (%) 
QI-10: Samples Number of samples haemolysed (haematology, 
chemistry) (%) 
QI-11: Samples Number of samples clotted (haematology, chemistry) 
(%) 
QI-12: Samples Number of samples with insufficient volumes (%) 
QI-13: Samples Number of samples with inadequate sample-
anticoagulant ratio (%) 
QI-14: Samples Number of samples damaged in transport (%) 
QI-15: Samples Number of improperly labelled samples (%) 
QI-16: Samples Number of improperly stored samples (%) 
 
In 2006, Plebani conducted a study using a methodology from 1996 to examine 
pre-analytical error rates concluding that the percentage of error had been left 
unchanged at approximately 60-70%. What did change was the source of the 
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error type within the pre-analytical phase. Errors involving incorrect collection 
tube types and requirements declined when staff committed to compliance of 
standard operating procedures (SOP). Meanwhile, an increase of errors was 
observed in patient identification despite the introduction of new information 
systems. Plebani attributes this shift of unsatisfactory compliance to widely-
distributed new written procedures; concluding the need to focus on close 
interdepartmental cooperation and compliance (2007). 
 
Microbiology laboratory consolidation into core laboratories have been more 
frequent in the U.S. due to funding and medical care reimbursement, and the 
need to increase efficiency (Sautter 2015). Core microbiology laboratories 
provide the space required for resources to perform microbiological tests in a 
central location to serve their affiliate facilities and hospitals in the region. 
Examples of these are the TPMG Regional laboratory in Berkeley, California that 
serves Kaiser Permanente hospitals and facilities, and Sutter Shared Laboratory 
in Livermore, California that serves it’s Sutter customers around the region. Due 
to the changing landscape of policies concerning healthcare, other areas in pre-
analytical phase require attention as well. Specimens travel long distances 
before undergoing testing, therefore transportation is an element of the pre-
preanalytical phase that also must be focused on (Plebani 2012).Transport of 
specimens can impact the perception of the laboratory when specimens are not 
accounted for and are unable to be tracked. In addition, the final steps in the pre-
preanalytical phase involve many hands-on sorting or routing, prior to allowing 
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automation to take over the next steps in the overall preanalytical phase of 
testing.  
 
Error decline has been observed the analytic phase due to standardization and 
improved quality controls and assurance methods; post-analytical errors have 
decreased as well thanks to technological advancements in information handling 
with laboratory information systems (LIS) linked instruments; even true pre-
analytical tasks of aliquoting, sorting, and processing have seen improvement in 
error rates impart by utilization of automation of robotic workstations (Plebani 
2012, Da Rin 2009). In addition, personnel undertaking roles in the analytical 
phase are commonly licensed professionals with a good understanding 
compliance with SOP. All of the aforementioned have one thing in common being 
that they are under the laboratory’s control. The pre-preanalytical phase is out of 
the laboratory’s control and errors can be reduce with the when using the right 
technological information tools alongside with active involvement and 
cooperation of human interactions to monitor compliance (Carraro et al 2012). In 
the present study, the focus is specimen accountability in a large microbiology 
core laboratory. Without the ability to use automation in the pre-preanalytical 
phase, interdepartmental coordination, compliance monitoring, and 
communication will be the method to compile data to identify quality indicators in 
large microbiology core laboratory. This data may be valuable for identifying 
problematic areas that may need further attention to ultimately reduce 
preanalytical errors.  
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CORE LABORATORY STUDY 
 
In this present study, the consolidated microbiology laboratory is simply identified 
as core lab. The multiple facilities that the core lab services are identified as 
sending facilities. The present study was performed between July through 
December 2017; data was collected at the end of the study.  
 
Interest in specimen accountability was sparked by an issue that was escalated 
to the quality department; requiring investigation and immediate resolution to 
prevent recurrence. The issue the core lab encountered involved a specimen on 
the core lab’s pending list for multiple days. The core lab’s’ LIS container tracking 
feature indicated that the specimen was in the lab and should have been 
completed.  
 
The lab assistant that supposedly logged in the specimen was held accountable 
for the specimen not reaching the test bench. The common practice for a sending 
facility to send a batch of specimens to the core lab is to build a Specimen 
Transfer List (STL), serving as packing list to account for specimens included in 
the biohazard bags. Creation of a STL automatically changes the status of those 
specimens from ‘collected’ to ‘in-transit’ status in the LIS. A third-party courier 
service is utilized to deliver shipments from multiple sending facilities to the core 
lab. Upon delivery lab personnel sort the biohazard bags, with specimens and 
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STL contained within them, manually into their respective bins according to type 
of test. Next, the assigned lab assistant for that test bench may gather their 
specimens and proceed to log in the specimens by list number. Logging in by list 
number generated by the LIS will log in all specimens on the STL. Status of the 
specimens is automatically updated to reflect that it has been received at the 
core lab and the test is pending. This is the point of fallacy in the process. 
Logging in by list number does not guarantee that specimens on the STL are 
truly the specimens in the bag, causing the lab assistant to be liable for the 
specimen.  
 
The missing specimen sparked concerns about who should be accountable for 
specimens when the sending specimen SOP is not complied with. Sending 
facilities are to comply with SOP to build an STL when sending specimens to the 
core lab. Instances have been observed when specimens are received at the 
core lab in ‘dispatched’ or ‘collected’ status, clearly without a STL. Types of 
status updates in the LIS are ‘dispatched’, ‘collected’, ‘in-transit’, ‘pending’, and 
'completed'; in that order. Each status serves as means to determine tests 
pending from day to day at each step of the testing process, from ordering to 
completion of results. ‘Dispatched’ status notifies healthcare personnel of 
pending collection, ‘collected’ status informs the local lab that the specimen 
should be arriving to the lab, and ‘in-transit’ indicates to the core lab that a 
specimen should be arriving within a certain time window. If a specimen is ‘in-
transit’ exceeding 48 hours, a “no specimen received” (NSR) email is sent to the 
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sending facility.  The specimen may be lost, not picked up, pending further 
instruction, and may require a recollect or recall of the patient.  Non-compliance 
practices have led to time wasted searching for specimens that have already 
reached its destination.  
 
Prior to this study frequency of STL non-compliance practice was uncertain. 
Specimens received without a STL at the core lab would be logged in and 
undergo processing. The concerning issue arises when specimens are truly lost 
and LIS tracking information indicates otherwise. Blame can be placed on either 
sending facility or core lab. Failure to comply with SOP leaves little evidence to 
where the specimen truly is. The purposes of complying with SOP and produce 
STL are to assist sending facilities to reconcile their pending lists, as well alert 
the core lab of possible transportation errors; it is the method to track specimens 
inter-departmentally.  
 
At the consolidate microbiology core laboratory where this study was performed, 
specimens are received from 70 hospitals and facilities. Specimen accountability 
is critical when dealing with high volume clinical core laboratories. Automation 
and enhanced information management can help reduce errors, but currently 
automation integration is slow due in part to the inherent variability involved in 
microbiology laboratories (Plebani 2006, Mulatero 2011). Automation of 
specimen receiving was out of the scope. Immediate changes had to be 
implemented to prevent issues of missing specimens and monitor non-compliant 
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practices. The aim of the this study is to 1) develop and implement a non-
automation solution to prevent missing specimens and, and 2) capture frequency 
in which non-compliant practices occur from sending facilities that can help assist 
with future solutions in a phase of TTP that already lacks well-define quality 
indicators.  
 
MATERIALS & METHODS 
 
The change proposed was implemented over a five month period and reflects 
issues encountered only during the night shift at the core lab. 
 
To increase accountability and provide quicker communication of problematic 
specimens, a managerial approach was utilized to modify current preanalytical 
work processes and duties to aid in identifying non-compliance QI. Current work 
processes prior to this study is depicted in Figure 1 with the ‘pre-preanalytical’ 
processes colored in orange spanning three areas: the sending facility, the 
courier, and the core lab. The in-lab ‘preanalytical’ phase of specimen processing 
for testing is boxed in green.  
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Figure 1. Process map prior to study depicting current processes of sending 
specimens to the core lab. 
 
Mitigating issues and capturing data for non-compliance from sending facilities 
required the addition of supplemental tasks. The major processes added were: 1) 
manually checking all specimens against their respective STL, 2) triaging 
specimens received in biohazard bags without STL, or vice versa, and 3) 
identifying STL that had multiple tests types ordered considered as ‘mixed STL’. 
The addition of the processes can be seen in Figure 2 which includes a method 
process to capture non-compliance events within the work shift to communicate 
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promptly any discrepancies; thereby improving accountability and releasing 
liability of missing specimens at the core lab.  
 
 
Figure 2. Process map after adjustments made to capture non-compliance 
practices when specimens are received at the core laboratory. 
 
Additional tasks required adjustment of existing work duties to ensure lab 
assistants were not overworked, maintaining the health and the ability to 
complete daily duties of the laboratory as a whole. Implementing change for 
sample handling that has many manual processing steps involved mapping out 
the process, measuring performance or compliance, showing results, simulation, 
simplifying and redesigning, and gaining consensus (Da Rin 2009). Lab 
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assistants played a vital role in adjusting tasks since they are familiar with the 
intensity and workload of assigned duties. Task adjustments were made in July 
and August 2017 and tested. Follow up meetings for input was conducted for two 
months until reaching a consensus what on new tasks each position were 
responsible for.  
 
Per procedure, sending facilities are to create a STL before sending out 
specimens, accurately pack specimens with corresponding patients on the STL, 
pack STL within the biohazard bags, and consistently make STL for only one test 
type. Mixed tests STL require additional handling at the core lab which increase 
the possibility of losing specimens. Any of these 4 issues encountered were 
placed in a problem bin that was centrally located near where the lab assistants 
performed manual sorting of specimens. The CLS/MLT who was in charge of 
sending emails to sending facilities monitored the problem bin and sent 
communication to the sending facilities, accordingly. 
 
Utilizing standardized email templates to communicate with sending facilities 
provided a means of monitoring non-compliance. Table 2 was the rubric 
developed to monitor these non-compliance issues and serve as quality 
indicators (QI) for the study. Collection of such data was useful for identifying the 
most problematic areas that required attention. The four situation types were 
chosen to be the most valuable scenarios to monitor concerning specimen 
accountability issues encountered at the core lab and non-compliance of the 
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sending facilities; providing possible solutions in the pre-preanalytical phase 
which lack well-defined quality indicators. 
 
Table 2. Rubric for Standardize Email of Non-compliance and definition of quality 
indicators 
Email Template Type Description Implications 
NSR Contents in bag missing 1 or 
more specimens omit from 
STL 
True error; missing 
specimen identified within 
shift hours; effect on 
patient care 
 Delayed specimen found on 
nightly pending list1 
Possible shared 
specimen, not collected, 
incorrect order, not picked 
up by courier, misrouted 
Collected/Dispatched 
Status 
No STL made; Specimen 
shipped without accountability 
from local laboratory 
Non-compliance w/o 
immediate effects on 
patient care 
STL/Specimen Separate or 
Mismatched STL 
Possible no STL made;no 
accountability from local 
laboratory 
Non-compliance w/o 
immediate effects on 
patient care 
Mixed Test STL Increases handling and 
sorting when received at 
Regional Laboratory; 
inefficiency and increase 
chance of losing specimen 
Non-compliance w/o 
immediate effects on 
patient care 
124 hours after collection time, or 8 hours after collection time for Group A Strep 
and influenza tests 
 
This method of surveillance and communication was applied to gather data on 
the complexity of the preanalytical phase and its initial steps prior to testing, and 
the importance of adhering to SOPs (Carraro 2012).   
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Data collected based on the pre-defined QI was retrieved at the end of the fifth 
month, December 2017. Volume of the four types of e-mails were tallied from the 
sent-box of the e-mail client. Any response back from the sending facility 
regarding the issue was noted. 
 
RESULTS 
 
Over the course of five months between July 2017 to December 2017, data was 
collected by using standardized emails. Standardized emails allowed for ease of 
grouping and quantifying the quality indicators as types of non-compliance 
monitored. Four types of non-compliance was monitored, 1) No specimen 
received (NSR) emails, 2) STL/Specimens separate from specimens, 3) Mixed 
STL, and 4) Collected/Dispatched status.  
 
Over the 5 months, 687 emails were communicated to sending facilities. Table 3 
below summarizes emails sent monthly based on the quality indicator 
categorizations for non-compliance monitoring. 
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Table 3. Total number of non-compliance emails sent between July to December 
2017. 
Month NSR1 Separated2 Mixed3 No STL4 
July 53 4 7 3 
August 62 27 20 44 
September 61 20 18 35 
October 64 24 7 37 
November 43 10 11 32 
December 62 5 11 27 
Totals 345 90 74 178 
1) No specimen received (NSR) emails, 2) STL/Specimens separate from 
specimens, 3) Mixed STL, and 4) Collected/Dispatched status, No STL made 
 
The NSR-type of non-compliance had the highest occurrence with 345 emails 
sent over the course of the study. Of the four types of non-compliance quality 
indicators, NSR issues and specimens sent without a STL produced were 
observed to be 50% and 26%, respectively.  Figure 3 visually represents the 
highest frequency of non-compliance issues to least frequent issues. Specimens 
not received to the core lab in a timely manner occurred more frequently and was 
further investigated. 
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Figure 3. Pareto chart of frequency of types of non-compliance emails sent from 
July to December 2017. NSR = 50%, Collected = 26%, STL/Specimens Separate 
= 13%, Mixed STL = 11%. 
 
Of the 345 NSR emails communicated to the sending facilities only 64 facilities 
responded back with explanation of the specimen accountability. The specimens 
not received were considered as 1) truly missing and identified as near-miss 
thereby relieved the core lab as accountable, 2) the core lab’s mistake of 
prematurely sending an NSR email when a specimen was later found in the core 
lab and was not logged in, or 3) an issue relating to courier services or other ‘pre-
preanalytical’ errors outside of the core lab such as requests to cancel, collection 
error, missed courier pick up, or misrouted. Figure 4 indicates the core lab was 
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accountable for more specimens missing in the early stages of the newly 
implemented work-flow; the following months the core lab had become more 
accountable for specimens reducing the number of email feedback for specimens 
that was sent an non-compliance e-mail. Truly missing specimens were identified 
in 10 incidences in a timely manner during the study and were considered as 
near-miss events that prevented delayed turnaround times. Accountability issues 
regarding the sending lab or courier appeared to remain constant without 
significant improvement. In the month of December there was a spike in emails 
sent that was attributed to a suspiciously high number missing specimens from 
one sending facility. This outier led to discovery of an entire shipment missed by 
the courier. Although timely communication allowed for quick action to locate the 
specimens, the specimens were delayed and still was categorized as an 
accountability issue regarding the sending facilities and courier. 
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Figure 4. 19% response rate of total NSR emails sent indicating outcome for 
cause of specimens not received to the core lab. 
 
A total of 345 NSR emails were sent to sending facilities; 64 responses were 
tracked. With a low response rate of 19%, the frequency of causes of not 
receiving specimens due that were 1) Sending Lab or courier related, 2) Core 
Lab accountable and, 3) truly missing specimen, or near-miss with prompt 
communication were presented in a pareto chart. Figure 5 indicates issues 
originating from the processes of the sending lab and/or courier comprises 67% 
of total specimens not received to the core lab. 
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Figure 5. Pareto chart of frequency of causes for NSR email to be sent from July 
to December 2017.  
 
DISCUSSION  
 
The value of the present five month study, by closely adhering to the changes of 
communicating non-compliance issues upon each encounter and monitoring 
workflow, is the ability to evaluate errors and survey non-conforming activities in 
the ‘pre-preanalytical’ clinical workflow (Carraro 2012). The complexity of 
preanalytical errors can be owed in part to the lack of well-define quality 
indicators. Pre-defining a laboratory’s own quality indicators in the preanalytical 
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phase should be established based on an institutions workflow to increase 
specimen accountability.  
 
As seen in the Figure 4, the initial implementation of the process changes by 
adding the manual task of scrutinizing each specimen to its STL did not result in 
immediate changes in the first two months of July and August. This can be 
possibly due to workflow changes and the understanding of new SOP steps. With 
the lack of automation and interdepartmental coordination, poor compliance of 
written procedures and increase in errors can be observed from overworked staff 
(Carraro 2007). Adjusting work duties and processes was effective with a 
consensus of the frontline workers in the lab. In the later months, the core lab’s 
specimen accountability increase as seen by the decrease of in outcome 
responses that indicated less claims of specimens not received when in fact they 
were in the core lab’s possession. This decrease confirms that the changes 
implemented at the core lab increased accountability. Meanwhile, the outcomes 
of missing or late specimens that showed no significant improvement can be 
traced back to non-compliance or inadequate processes that are sending lab or 
courier related.  
 
While monitoring quality indicators in the pre-analytical phase does not 
necessarily translate into quality improvement, it can help identify problematic 
processes and promote the need for appropriate preparation, understanding, and 
monitoring of SOP compliance (Plebani 2012). This present study highlighted 
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issues that needed to be addressed without the assistance of automation. 
Monitoring compliance and adjusting work process were beneficial for specimen 
accountability in the core lab as the study progressed. Future considerations to 
decrease errors in the TTP should include a team to work with outside sending 
facilities and healthcare personnel. This study primarily used standardized email 
templates as a means to communicate and quantitate QI. A response rate of 
19% regarding non-compliance issues is too low to indicate any definite probable 
causes or effects in concerns with the high volume of NSR emails sent out. 
Figure 5 indicates that sending facilities compliance and courier related causes of 
no specimens received to the core lab would be an ideal initial area to focus on in 
the future. With a dedicated outreach team or group to stress the importance of 
SOP adherence and a significant increase of response communication to issues 
may in turn promote decrease in error rates.  
 
Similar to Carraro’s findings in 2012, when the core lab closely monitored non-
compliance and communicated with outside facilities, it was possible to observe 
the complexity of the pre-pre-analytical errors and error mitigation due to the 
performance of external facilities that are out of the laboratories control. In 
addition, a consensus process should be used to develop procedures from both 
sending and receiving facilities to further understand the implications of deviating 
from procedures, and provide a commitment to adhere to those standard 
operating procedures to further increase the accountability of specimens (Carraro 
2012). 
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